MDR – Medical Device Regulation: The European Medical Device Regulation

The MDR (Medical Device Regulation, EU Regulation 2017/745) is the established regulatory framework governing medical devices across the European Union since May 2021. This regulation supersedes the previous directives MDD 93/42/EEC and AIMDD 90/385/EEC, introducing significantly stricter compliance requirements for manufacturers, importers, and distributors of a variety of medical devices, ranging from adhesive bandages to complex implantable devices like pacemakers.

The MDR includes critical changes such as a revised risk classification system (Classes I, IIa, IIb, III) with increased requirements for higher-risk categories, enhanced standards for clinical evaluations—including demanding clinical evidence rather than solely relying on literature reviews—mandatory Post-Market Clinical Follow-up (PMCF) for continual monitoring of clinical benefits post-market, a strengthening of mandates for Notified Bodies, and an extensive Unique Device Identification (UDI) system aimed at improving traceability for each medical device.

Notified Bodies, which include organizations such as TÜV SÜD, TÜV Rheinland, and BSI (UK), are responsible for reviewing conformity assessments for Class IIa, IIb, and III products. Alternatively, for Class I products that do not involve measuring functionality and are not supplied sterile, manufacturers may self-certify. The compliance of a medical device with the MDR is indicated by the CE marking. The EUDAMED database managed by the EMA keeps a record of all registered products, manufacturers, and incident reports associated with medical devices.

Alongside the MDR, the IVDR (EU Regulation 2017/746) concerning in vitro diagnostics has been in effect since May 2022, enforcing similarly stringent requirements for diagnostic manufacturers. The implications of the MDR are particularly significant for medical device companies operating in Germany, where its implementation has led to a considerable regulatory burden as many existing products require reassessment and recertification. Smaller manufacturers often encounter heightened challenges navigating these regulations.

The oversight of MDR compliance falls to national market surveillance authorities, such as BfArM in Germany for non-invasive products and also DIMDI (now integrated with BfArM) along with state authorities. Incidents and recalls must be reported through the European EUDAMED system. Due to the rigorous requirements stipulated by the MDR, many manufacturers opt to outsource regulatory affairs to specialized service providers or partner with seasoned contract manufacturers that possess MDR expertise.

Medical device companies in Germany | ← Back to glossary

Legal Framework

The MDR provides a comprehensive legal framework aimed at ensuring that medical devices are safe and effective for public health. It is part of a broader effort by the European Union to harmonize medical device regulation across its member states. The regulation emphasizes a risk-based approach, ensuring that the level of scrutiny applied to a device corresponds to the potential risks associated with its use. The legal basis of the MDR is characterized by several pivotal elements:

• Risk-Based Classification: Devices are categorized into four classes—Class I (low risk), Class IIa (medium risk), Class IIb (higher medium risk), and Class III (high risk). Each class has distinct regulatory requirements.
• Clinical Evidence Requirement: Manufacturers must present robust clinical data to demonstrate a device's safety and performance, lessening reliance on literature and ensuring comprehensive evaluations of clinical outcomes.
• Post-Market Surveillance: Requirements for PMCF and PMS (Post-Market Surveillance) are mandatory to observe the continued safety and efficacy of the devices once they are on the market.
• Notified Bodies: These organizations, designated by EU countries, play a crucial role in evaluating and certifying compliance of higher-class devices, ensuring they meet all regulatory expectations.

Practical Relevance

The practical relevance of the MDR cannot be overstated; it has significant implications for all stakeholders involved in the medical device supply chain. For manufacturers, compliance means investing in new processes and systems to align with regulatory expectations, including:

• Increased Costs: Companies face heightened costs associated with rigorous testing, documentation, and approval processes. Compliance may require financial investment for hiring experts and updating technological capabilities.
• Market Access Challenges: The heightened complexity of the regulatory landscape may pose barriers to entering the EU market, particularly for smaller manufacturers who may lack the resources to navigate the requirements.
• Liability and Accountability: The post-market requirements demand ongoing monitoring of devices, which holds manufacturers accountable for the performance and safety throughout the product lifecycle.

Related Terms

• IVDR: In Vitro Diagnostic Regulation, which regulates diagnostic testing products and devices, offering similar compliance structures to those of the MDR.
• Notified Body: A designated organization that assesses the conformity of medical devices before they can be marketed in the EU.
• CE Marking: A certification mark indicating that a medical device complies with EU safety, health, and environmental protection standards.
• PMCF: Post-Market Clinical Follow-Up, a process required under the MDR to collect and analyze data concerning the ongoing performance of a device in the market.

Common Questions

What is the primary goal of the MDR?

The primary goal of the MDR is to ensure that medical devices placed on the European market are safe and perform as intended, thereby protecting patient health and safety.

How does the MDR affect manufacturers of medical devices?

The MDR imposes stricter regulatory requirements on manufacturers, including the need for thorough clinical evaluations, comprehensive documentation, and ongoing post-market surveillance to ensure continued device safety and effectiveness.

Who is responsible for monitoring MDR compliance?

National market surveillance authorities are responsible for monitoring compliance with the MDR, along with Notified Bodies who conduct assessments for higher-class medical devices.

What happens if a device does not comply with the MDR?

If a medical device does not comply with the MDR, it cannot be marketed in the EU, and manufacturers could face penalties, recalls, or other enforcement actions from regulatory authorities.